Table ES1: RCT Evidence for Ultraviolet Phototherapy Treatment of Moderate-To-Severe Plaque Psoriasis |
Table 1. Level of Evidence Summary for Studies Included in MAS Review |
Table 2. Ultraviolet Phototherapy Management of Psoriasis: RCT Evidence (1999 to May 2009) |
Table 3. Effectiveness of Different UVB Wavelengths for Moderate-To-Severe Plaque Psoriasis |
Table 4. Treatment Comparisons of UVB Phototherapy and UVA Photochemotherapy for Moderate-To-Severe Plaque Psoriasis |
Table 5. Phototherapy Alone and in Combination Therapy with Topical Agents for Moderate-To-Severe Plaque Psoriasis |
Table 6. Impact of Balneotherapy On Phototherapy Treatment Effectiveness for Moderate-To-Severe Plaque Psoriasis |
Table 7. Impact of Systemic Agents Added to Phototherapy for Management of Moderate-To-Severe Plaque Psoriasis |
Table 8. Impact of The Excimer Laser as an Additional Light Source on Photochemotherapy Management of Moderate-to-Severe Plaque Psoriasis |
Table 9. Effectiveness of Concurrent Mindfulness and Stress Reduction Audiotape Sessions With Phototherapy or Photochemotherapy For Moderate-To-Severe Plaque Psoriasis |
Table 10. Comparison of Inpatient Dithranol, Outpatient Dithranol or Phototherapy Treatment Of Moderate-To-Severe Plaque Psoriasis |
Table 11. Outpatient Clinic Versus Home-Based Phototherapy Treatment for Plaque Psoriasis |
Table 12. GRADE Quality of Evidence for Phototherapy Management of Moderate-to-Severe Psoriasis |
Table 13. Summary of RCT Evidence for Ultraviolet Phototherapy Management of Moderate-To-Severe Plaque Psoriasis |
Table 14. Average Annual Costs Per Patient of NB-UVB Phototherapy by Type of Setting |